Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.15
73% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $1.6M | $4.1M | $3.4M | $0 | $0 | $2.7M |
| Gross profit | $0 | $0 | −$1.6M | −$4.1M | −$3.4M | $0 | $0 | −$2.7M |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $10.8M | $11.1M | $11.4M | $20.8M | $21.3M | $18.6M | $17.6M | $11.2M |
| Operating income | −$18.4M | −$20.9M | −$19.4M | −$64.7M | −$37.0M | −$29.8M | −$27.8M | −$22.5M |
| EBITDA | −$18.2M | −$20.7M | −$18.4M | −$88.0M | −$35.1M | −$28.1M | −$26.2M | −$19.8M |
| Net income | −$18.7M | −$22.2M | −$22.0M | −$90.1M | −$38.7M | −$28.5M | −$27.8M | −$24.4M |
| Net margin | — | — | — | — | — | — | — | — |
| EPS (diluted) | -0.02 | -0.03 | -0.02 | -0.08 | -0.03 | -0.02 | -0.02 | -0.04 |
Annual figures · source: Financial Modeling Prep
BONUS BIOGROUP LTD
No one on the platform currently holds BBIXF.
No tracked institution reports a position in BBIXF as of their last filing.
No one on the platform has traded BBIXF yet.
| $16M |
| — |
| FNCHFinch Therapeutics Group, Inc. | $8.70 | +16.00% | $14M | — |
| IPDQFImpediMed Limited | $0.01 | -1.96% | $10M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.